Compounders Research Compare

Climb Bio, Inc.(CLYM)

Biotechnology · Wellesley Hills, MA

$11.05+0.11 (+1.01%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Climb Bio, Inc.

Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.

Wellesley Hills, MA

28 employees

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Aoife Brennan BCh MMSc

View full financials

Climb Bio (CLYM) Interest Coverage Ratio: History & Chart | TGMCharts

Interest Coverage Ratio: N/A

Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.

The interest coverage ratio is N/A as of Tuesday, October 6, 2026.

Interest Expense|Total Debt|Debt/Equity|Operating Margin|All Metrics

CLYM Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

N/A

CLYM Competitors' Interest Coverage Ratio

Climb Bio, Inc.

Current

Market Cap

$632.76M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Fulgent Genetics, Inc.

Market Cap

$637.59M

Interest Coverage Ratio

-1214.61x

TTM Avg

176.24x

3Y Avg

176.24x

5Y Avg

176.24x

AngioDynamics, Inc.

Market Cap

$642.31M

Interest Coverage Ratio

-133.54x

TTM Avg

0.30x

3Y Avg

1.45x

5Y Avg

7.08x

Aura Biosciences, Inc.

Market Cap

$643.37M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aclaris Therapeutics, Inc.

Market Cap

$596.36M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

4D Molecular Therapeutics, Inc.

Market Cap

$675.41M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BlossomHill Therapeutics, Inc.

Market Cap

$579.88M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Annexon, Inc.

Market Cap

$688.14M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aquestive Therapeutics, Inc.

Market Cap

$573.38M

Interest Coverage Ratio

-4.07x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CorMedix Inc.

Market Cap

$569.56M

Interest Coverage Ratio

53.97x

TTM Avg

53.97x

3Y Avg

53.97x

5Y Avg

53.97x

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Climb Bio, Inc. (CLYM)	$632.76M	N/A	N/A	N/A	N/A
Fulgent Genetics, Inc. (FLGT)vs ›	$637.59M	-1214.61x	176.24x	176.24x	176.24x
AngioDynamics, Inc. (ANGO)vs ›	$642.31M	-133.54x	0.30x	1.45x	7.08x
Aura Biosciences, Inc. (AURA)vs ›	$643.37M	N/A	N/A	N/A	N/A
Aclaris Therapeutics, Inc. (ACRS)vs ›	$596.36M	N/A	N/A	N/A	N/A
4D Molecular Therapeutics, Inc. (FDMT)vs ›	$675.41M	N/A	N/A	N/A	N/A
BlossomHill Therapeutics, Inc. (BLSM)vs ›	$579.88M	N/A	N/A	N/A	N/A
Annexon, Inc. (ANNX)vs ›	$688.14M	N/A	N/A	N/A	N/A
Aquestive Therapeutics, Inc. (AQST)vs ›	$573.38M	-4.07x	N/A	N/A	N/A
CorMedix Inc. (CRMD)vs ›	$569.56M	53.97x	53.97x	53.97x	53.97x

Financial Health Indicators

Interest Coverage

N/A

Debt/Equity

0.01

Current Ratio

31.45

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

< 1.5x: EBIT is less than 1.5 times interest expense
1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
3x - 5x: EBIT is between 3 and 5 times interest expense
> 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

Interest Expense Total Debt Debt/Equity Operating Margin All Metrics